Rezolute, Inc.
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibod…
Biotechnology
US, Redwood City [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Rezolute, Inc.'s gradings, price targets and earnings estimates. None
Reported
Past Estimate Consensus
Future Estimate Consensus
Rezolute, Inc. can't present any analysts estimates at the moment detail analysis.